Abstract
The comparative long-term antianginal efficacy of long-acting nitrates versus calcium channel antagonists remains unclear. The goal of the present study was to compare the coronary endothelial cell function and coronary artery vasoconstriction between patients with normal or mildly diseased coronary arteries treated with long-acting nitrates or calcium channel antagonists. Forty-two patients suspected to have angina pectoris and with normal or mildly diseased coronary arteries underwent Doppler flow study of the left anterior descending coronary artery. All patients were suspected to have angina pectoris and were receiving either long-acting nitrates (n = 18; Nitrates group) or calcium channel antagonists (n = 24; Ca-antagonists group) for at least 1 year. Vascular reactivity was assessed by intracoronary administration of papaverine, acetylcholine (Ach), and nitroglycerin using a Doppler guidewire. Segments that showed the greatest constrictive response to Ach were used for assessment of vasoconstriction. The percent increase in coronary blood flow (CBF) and coronary artery diameter (CAD) induced by Ach was significantly smaller in the Nitrates group than in the Ca-antagonists group (33% ± 74% vs 83% ± 77%, P < 0.05; −3% ± 16% vs 11% ± 12%, P < 0.01, respectively). The percent diameter reduction in the region of greatest constrictive response to Ach was significantly greater in the Nitrates group than in the Caantagonists group (44% ± 39% vs 15% ± 32%, P < 0.02). Long-term treatment with long-acting nitrates may produce less favorable effects on coronary endothelial function and the constrictive response to Ach when compared with long-acting calcium channel antagonists in patients with normal or mildly diseased coronary arteries.
Similar content being viewed by others
References
Yusuf S, Collins R, McMahon S, Peto R (1988) Effect of intravenous nitrates on mortality in acute myocardial infarction: An overview of the randomized trials. Lancet 1:1088–1092
Jugdutt BI (1992) Role of nitrates after acute myocardial infraction. Am J Cardiol 70:82B–87B
GISSI-3 (1994) Effects of lisinopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction. Gruppo Italiano per lo Studio della Sopravvivenza nell’infarto Miocardico. Lancet 343:1115–1122
ISIS-4 (1995) A randomized factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58,050 patients with suspected acute myocardial infarction. Lancet 345:669–685
Ishikawa K, Kanamasa K, Ogawa I, Takenaka T, Naito T, Kamata N, Yamamoto T, Nakai S, Hama J, Oyaizu M, Kimura A, Yamamoto K, Aso N, Arai M, Yabushita H, Katori R (1996) Long-term nitrate treatment increases cardiac events in patients with healed myocardial infarction. Jpn Circ J 60:779–788
Munzel T, Giaid A, Kurz S, Stewart DJ, Harrison DG. (1995) Evidence for a role of endothelin 1 and protein kinase C in nitroglycerin tolerance. Proc Natl Acad Sci USA 92:5244–5248
Zierhut W, Ball HA (1996) Prevention of vascular nitroglycerin tolerance by inhibition of protein kinase C. Br J Pharmacol 119:3–5
Heitzer T, Just H, Meinertz T, Brockhoff C, Munzel T (1998) Chronic angiotensin converting enzyme inhibition with captopril prevents nitroglycerin induced hypersensitivity to vasoconstrictors in patients with stable coronary artery disease. J Am Coll Cardiol 31:83–88
Furberg CD, Psaty BM, Meyer JV (1995) Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 92:1326–1331
Thadani U, Glasser S, Bittar N, Beach CI (1994) Dose-response evaluation of once-daily therapy with a new formation of diltiazem for stable angina pectoris. Diltiazem CD Study Group. Am J Cardiol 74:9–17
Gibbs JS, McAlpine HM, Wright C, McLenachan JM, Sparrow J, Sutton G, Dargie HJ, Fox KM (1991) Double-blind randomized placebo-controlled dose-efficacy study of sustained release verapamil in chronic stable angina. Int J Cardiol 31:281–286
Poole-Wilson PA, Lubsen J, Kirwan BA, van Dalen FJ, Wagener G, Danchin N, Just H, Fox KA, Pocock SJ, Clayton TC, Motro M, Parker JD, Bourassa MG, Dart AM, Hildebrandt P, Hjalmarson A, Kragten JA, Molhoek GP, Otterstad JE, Seabra-Gomes R, Soler-Soler J, Weber S; A Coronary disease Trial Investigating Outcome with Nifedipine gastrointestinal therapeutic system investigators (2004) Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomized controlled trial. Lancet 364:849–857
Nissen SE, Tuzcu EM, Libby P, Thompson PD, Ghali M, Garza D, Berman L, Shi H, Buebendorf E, Topol EJ; CAMELOT Investigators (2004) Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 292:2217–2225
Pitt B, Byington RP, Furberg CD, Hunninghake DB, Mancini GB, Miller ME, Riley W (2000) Effect of amlodipine on the progression of atherosclerosis and the occurrence of clinical events. PREVENT Investigators. Circulation 102:1503–1510
Egashira K (2002) Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J 66(6):529–533
Egashira K, Suzuki S, Hirooka Y, Kai H, Sugimachi M, Imaizumi T, Takeshita A (1995) Impaired endothelium-dependent vasodilation of large epicardial and resistance coronary arteries in patients with essential hypertension. Different responses to acetylcholine and substance P. Hypertension 25(2):201–206
Zeiher AM, Schachinger V, Minners J (1995) Long-term cigarette smoking impairs endothelium-dependent coronary arterial vasodilator function. Circulation 92(5):1094–1100
Matsuo T, Iwade K, Hirata N, Yamashita M, Ikegami H, Tanaka N, Aosaki M, Kasanuki H (2005) Improvement of atrial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia. Heart Vessels 20(1):8–12
Takagi A, Tsurumi Y, Ishizuka N, Omori H, Arai K, Hagiwara N, Kasanuki H (2006) Single administration of cerivastatin, an HMD-CoA reductase inhibitor, improves the coronary flow velocity reserve: a transthoracic Doppler echocardiography study. Heart Vessels 21(5):298–301
Nishimura RA, Lerman A, Chesebro JH, Ilstrup DM, Hodge DO, Higano ST, Holmes DR Jr, Tajik AJ (1995) Epicardial vasomotor responses to acetylcholine are not predicted by coronary atherosclerosis as assessed by intracoronary ultrasound. J Am Coll Cardiol 26:41–49
Lerman A, Holmes DR Jr., Bell MR, Garratt KN, Nishimura RA, Burnett JC Jr (1995) Endothelin in coronary endothelial dysfunction and early atherosclerosis in humans. Circulation 92:2426–2431
Hasdai D, Gibbons RJ, Holmes DR Jr., Higano ST, Lerman A (1997) Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects. Circulation 96:3390–3395
Egashira K, Inou T, Hirooka Y, Kai H, Sugimachi M, Suzuki S, Kuga T, Urabe Y, Takeshita A (1993) Effects of age on endothelium-dependent vasodilation of resistance coronary artery by acetylcholine in humans. Circulation 88:77–81
Fukuda Y, Teragawa H, Matsuda K, Yamagata T, Matsuura H, Chayama-K (2002) Tetrahydrobiopterin restores endothelial function of coronary arteries in patients with hypercholesterolemia. Heart 87:264–269
Ishida S, Hamasaki S, Kamekou M, Yoshitama T, Nakano F, Yoshikawa A, Kataoka T, Saihara K, Minagoe S, Tei C (2003) Advancing age is associated with diminished vascular remodeling and impaired vasodilation in resistance coronary arteries. Coronary Artery Dis 14:443–449
Doucette JW, Corl PD, Payne HM, Flynn AE, Goto M, Nassi M, Segal J (1992) Validation of a Doppler guide wire for intravascular measurement of coronary artery flow velocity. Circulation 85:1899–1911
de Simone G, Devereux RB, Chien S, Alderman MH, Atlas SA, Laragh JH (1990) Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation 81:107–117
Nakamura Y, Moss AJ, Brown MW, Kinoshita M, Kawai C (1999) Long-term nitrate use may be deleterious in ischemic heart disease: A study using the databases from two large-scale postinfarction studies. Am Heart J 138:577–585
Moss AJ, Goldstein RE, Hall WJ, Bigger JT Jr., Fleiss JL, Greenberg H, Bodenheimer M, Krone RJ, Marcus FI, Wackers FJ, Benhorin J, Brown MW, Case R, Coromilas J, Dwyer EM Jr., Gillespie JA, Gregory JJ, Kleiger R, Lichstein E, Parker JO, Raubertas RF, Stern S, Tzivoni D, Voorhees LV, for the Multicenter Myocardial Ischemia Group (1993) Detection and significance of myocardial ischemia in stable patients after recovery from an acute coronary event. Multicenter Myocardial Ischemia Research Group. JAMA 269:2379–2385
The Multicenter Diltiazem Post-infarction Trial Group (1988) The effect of diltiazem on mortality and reinfarction after myocardial infraction. N Engl J Med 319:385–392
Caramori PR, Adelman AG, Azevedo ER, Newton GE, Parker AB, Parker JD (1998) Therapy with nitroglycerin increases coronary vasoconstriction in response to acetylcholine. J Am Coll Cardiol 32(7):1969–1974
Parker JD, Gori T (2001) Tolerance to the organic nitrates: new ideas, new mechanisms, continued mystery. Circulation 104(19):2263–2265
Mangione NJ, Glasser SP (1994) Phenomenon of nitrate tolerance. Am Heart J 128:137–146
Dupuis J, Lalonde G, Lemieux R, Rouleau JL (1990) Tolerance to intravenous nitroglycerin in patients with congestive heart failure: role of increased intravascular volume, neurohumoral activation and lack of prevention with N-Acetylcysteine. J Am Coll Cardiol 16:923–931
Keller LH, Hulley SB, Cohen JD, Neaton J (1986) Unexpected effects of treating hypertension in men with electrocardiographic abnormalities: a critical analysis. Circulation 73:114–123
Topper JN, Cai J, Falb D, Gimbrone MAJ (1996) Identification of vascular endothelial genes differentially responsive to fluid mechanical stimuli: cyclooxygenase-2, manganese superoxide dismutase, and endothelial cell nitric oxide synthase are selectively up-regulated by steady laminar shear stress. Proc Natl Acad Sci USA 93:10417–10422
Feron O, Dessy C, Moniotte S, Desager JP, Balligand JL (1999) Hypercholesterolemia decreases nitric oxide production by promoting the interaction of caveolin and endothelial nitric oxide synthase. J Clin Invest 103:897–905
Chou TC, Yen MH, Li CY, Ding YA (1998) Alterations of nitric oxide synthase expression with aging and hypertension in rats. Hypertension 31:643–648
Kawano H, Motoyama T, Hirashima O, Hirai N, Miyao Y, Sakamoto T, Kugiyama K, Ogawa H, Yasue H (1999) Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery. J Am Coll Cardiol 34:146–154
Oemar BS, Tschudi MR, Godoy N, Brovkovich V, Malinski T, Luscher TF (1998) Reduced endothelial nitric oxide synthase expression and production in human atherosclerosis. Circulation 97:2494–2498
Davies PF (1995) Flow-mediated endothelial mechanotransduction. Physiol Rev 75:519–560
Gimbrone MA Jr, Topper JN, Nagel T, Anderson KR, Garcia-Cardena G (2000) Endothelial dysfunction, hemodynamic forces, and atherogenesis. Ann N Y Acad Sci 902:230–239
Gotlieb AI, Langille BL (1996) The role of rheology in atherosclerotic coronary artery disease. In: Fuster V, Ross R, Topol EJ (eds) Atherosclerosis and coronary artery disease. Lippincott-Raven, Philadelphia, pp 595–606
Ben Drias A, Benessiano J, Poitevin P, Levy BI, Michel JB (1997) Arterial expansive remodeling induced by high flow rates. Am J Physiol 272:H851–858
Fukaya Y, Ohhashi T (1996) Acetylcholine-and flow-induced production and release of nitric oxide in arterial and venous endothelial cells. Am J Physiol 270:H99–106
Griscavage JM, Fukuto JM, Komori Y, Ignarro LJ (1994) Nitric oxide inhibits neuronal nitric oxide synthase by interacting with the heme prosthetic group. Role of tetrahydrobiopterin in modulating the inhibitory action of nitric oxide. J Biol Chem 269:21644–21649
Suwaidi J AL, Hamasaki S, Higano ST, Nishimura RA, Holmes DR Jr, Lerman A (2000) Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101:948–954
Schachinger V, Britten MB, Zeiher AM (2000) Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease. Circulation 101:1899–1906
Zeiher AM, Drexeler H, Wollschlyger H, Just H (1991) Modulation of coronary vascular tone in humans: progressive endothelial dysfunction with different early stages of coronary atherosclerosis. Circulation 83:391–401
De Caterina R, Libby P, Peng HB, Thannickal VJ, Rajavashisth TB, Gimbrone MA Jr, Shin WS, Liao JK (1995) Nitric oxide decreases cytokine-induced endothelial activation: nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J Clin Invest 96:60–68
van der Wal AC, Becker AE, van der Loos CM, Das PK (1994) Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaque is characterized by an inflammatory process irrespective of the dominant plaque morphology. Circulation 89:36–44
Zeiher AM, Krause T, Schachinger V, Minners J, Moser E (1995) Impaired endothelium-dependent vasodilation of coronary resistance vessels is associated with exercise-induced myocardial ischemia. Circulation 91:2345–2352
Beltrame JF, Sasayama S, Maseri A (1999) Racial heterogeneity in coronary artery vasomotor reactivity: differences between Japanese and Caucasian patients. J Am Coll Cardiol 33:1442–1452
Author information
Authors and Affiliations
Corresponding author
Additional information
These authors contributed equally to this study.
Rights and permissions
About this article
Cite this article
Ninomiya, Y., Hamasaki, S., Saihara, K. et al. Comparison of effect between nitrates and calcium channel antagonist on vascular function in patients with normal or mildly diseased coronary arteries. Heart Vessels 23, 83–90 (2008). https://doi.org/10.1007/s00380-007-1019-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00380-007-1019-4